These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35134821)

  • 1. Validity of continuous glucose monitoring for categorizing glycemic responses to diet: implications for use in personalized nutrition.
    Merino J; Linenberg I; Bermingham KM; Ganesh S; Bakker E; Delahanty LM; Chan AT; Capdevila Pujol J; Wolf J; Al Khatib H; Franks PW; Spector TD; Ordovas JM; Berry SE; Valdes AM
    Am J Clin Nutr; 2022 Jun; 115(6):1569-1576. PubMed ID: 35134821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprecision nutrition? Different simultaneous continuous glucose monitors provide discordant meal rankings for incremental postprandial glucose in subjects without diabetes.
    Howard R; Guo J; Hall KD
    Am J Clin Nutr; 2020 Oct; 112(4):1114-1119. PubMed ID: 32766882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients.
    Price CE; Fanelli JE; Aloi JA; Anzola SC; Vishneski SR; Saha AK; Woody CC; Segal S
    J Clin Anesth; 2023 Aug; 87():111090. PubMed ID: 36913777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-induced differences in estimated plasma glucose concentrations in healthy, non-diabetic adults are detected by continuous glucose monitoring-a randomized crossover trial.
    Fechner E; Op 't Eyndt C; Mulder T; Mensink RP
    Nutr Res; 2020 Aug; 80():36-43. PubMed ID: 32679434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense Continuous Glucose Monitoring Devices in a Home-Use Study of Subjects with Type 1 Diabetes.
    Jafri RZ; Balliro CA; El-Khatib F; Maheno MM; Hillard MA; O'Donovan A; Selagamsetty R; Zheng H; Damiano ER; Russell SJ
    Diabetes Technol Ther; 2020 Nov; 22(11):846-852. PubMed ID: 32453604
    [No Abstract]   [Full Text] [Related]  

  • 6. Discordance between postprandial plasma glucose measurement and continuous glucose monitoring.
    Barua S; A Wierzchowska-McNew R; Deutz NEP; Sabharwal A
    Am J Clin Nutr; 2022 Oct; 116(4):1059-1069. PubMed ID: 35776949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.
    Rein M; Ben-Yacov O; Godneva A; Shilo S; Zmora N; Kolobkov D; Cohen-Dolev N; Wolf BC; Kosower N; Lotan-Pompan M; Weinberger A; Halpern Z; Zelber-Sagi S; Elinav E; Segal E
    BMC Med; 2022 Feb; 20(1):56. PubMed ID: 35135549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals.
    Mendes-Soares H; Raveh-Sadka T; Azulay S; Ben-Shlomo Y; Cohen Y; Ofek T; Stevens J; Bachrach D; Kashyap P; Segal L; Nelson H
    Am J Clin Nutr; 2019 Jul; 110(1):63-75. PubMed ID: 31095300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
    Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
    Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-retest reliability of a continuous glucose monitoring system in individuals with type 2 diabetes.
    Terada T; Loehr S; Guigard E; McCargar LJ; Bell GJ; Senior P; Boulé NG
    Diabetes Technol Ther; 2014 Aug; 16(8):491-8. PubMed ID: 24815725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral glucose tolerance test and ambulatory glycaemic profiles in pregnant women in Uganda with gestational diabetes using the FreeStyle Libre flash glucose monitoring system.
    Milln JM; Walugembe E; Ssentayi S; Nkabura H; Jones AG; Nyirenda MJ
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):635. PubMed ID: 33076849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial changes in cardiometabolic disease risk in young Chinese men following isocaloric high or low protein diets, stratified by either high or low meal frequency - a randomized controlled crossover trial.
    Mok A; Haldar S; Lee JC; Leow MK; Henry CJ
    Nutr J; 2016 Mar; 15():27. PubMed ID: 26979583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs.
    Naguib MN; Hegedus E; Raymond JK; Goran MI; Salvy SJ; Wee CP; Durazo-Arvizu R; Moss L; Vidmar AP
    Front Endocrinol (Lausanne); 2022; 13():841838. PubMed ID: 35282464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of structured Ramadan Nutrition Plan on glycemic control and variability using continuous glucose monitoring in individuals with type 2 diabetes: A pilot study.
    Hasbullah FY; Mohd Yusof BN; Wan Zukiman WZHH; Abu Zaid Z; Omar N; Liu RXY; Marczewska A; Hamdy O
    Diabetes Metab Syndr; 2022 Oct; 16(10):102617. PubMed ID: 36174477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics.
    Pleus S; Kamecke U; Waldenmaier D; Link M; Zschornack E; Jendrike N; Haug C; Freckmann G
    J Diabetes Sci Technol; 2021 Sep; 15(5):1104-1110. PubMed ID: 32513087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
    Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
    J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.